# Recurrent Persistent Atrial Fibrillation:In-situ Ablation Vs Extensive Ablation

> **NCT06829446** · NA · COMPLETED · sponsor: **Shanghai Chest Hospital** · enrollment: 132 (actual)

## Conditions studied

- Recurrent Persistent Atrial Fibrillation

## Interventions

- **PROCEDURE:** Extra-PV extensive ablation
- **PROCEDURE:** Repeat same PVI and linear ablation as the first procedure

## Key facts

- **NCT ID:** NCT06829446
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2025-02-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06829446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06829446, "Recurrent Persistent Atrial Fibrillation:In-situ Ablation Vs Extensive Ablation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06829446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*